HOMA-IR as a Screening Test in NAFLD

Completed

• Conditions: NAFLD

• Registration Number: NCT04084925
• Lead Sponsor: Fayoum University

Brief Summary

The aim of this study is to evaluate the role of HOMA-IR in diagnosis of NAFLD in patients with type 2 DM.

Detailed Description

this study is a retrospective cohort study included 100 patients with type 2 DM from the outpatient clinic of internal medicine department at Fayoum University Hospital. They were divided into two equal groups according to the presence of NAFLD by ultrasound. All patients were subjected to history taking, clinical examination and investigations which included: ALT, AST, total cholesterol, TG, FBG and fasting insulin level,HOMA-IR(Homeostatic Model Assessment for Insulin Resistance) assessment.

Study Timeline

• Study Start: 2017-12-01
• Primary Completion: 2018-06-20
• Study Completion: 2018-12-20
• Status Verified: 2019-09
• Study First Submitted: 2019-09-03
• Study First Submitted QC: 2019-09-07
• Study First Posted: 2019-09-10
• Last Update Submitted: 2019-09-10
• Last Update Posted: 2019-09-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Diabetes obesity

Exclusion Criteria

• use of alcohol

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The correlation between HOMA-IF and NAFLD	6 months	Find a statistically significant correlation between HOMA IR and NAFLD in diabetics

Trial Locations

Locations (1)

Fayoum university hospital; 🇪🇬 Fayoum, Egypt